Genic Competitors

Stocks Korea . 
Stock . Genic Co
123330 Stock  KRW 21,250  1,000.00  4.49%   
Genic competes with FoodNamoo, Polaris Office, Korea Electronic, Wave Electronics, and Hankook Furniture; as well as few others. Analyzing Genic competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Genic to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Genic Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Genic competition on your existing holdings.
  
Hype
Prediction
LowEstimatedHigh
21,24421,25021,256
Details
Intrinsic
Valuation
LowRealHigh
17,03317,03923,375
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Genic. Your research has to be compared to or analyzed against Genic's peers to derive any actionable benefits. When done correctly, Genic's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Genic.

Genic Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Genic and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Genic and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Genic does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
263600
+ 0.96
041460
095270
+ 0.95
041460
263600
+ 0.92
095270
008060
+ 0.86
004590
057050
+ 0.79
041460
057050
+ 0.79
095270
  
High negative correlations   
008060
- 0.83
095270
008060
- 0.82
041460
008060
- 0.8
263600
004590
- 0.72
095270
263600
- 0.7
004590
004590
- 0.7
041460

Risk-Adjusted Indicators

There is a big difference between Genic Stock performing well and Genic Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Genic's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Genic Competitive Analysis

The better you understand Genic competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Genic's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Genic's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
123330 290720 041020 041460 095270 004590 263600 008060 057050
 4.49 
 21,250 
Genic
 3.19 
 2,880 
FoodNamoo
 3.45 
 5,700 
Polaris
 2.59 
 2,970 
Korea
 0.39 
 3,870 
Wave
 0.74 
 4,040 
Hankook
 2.01 
 4,875 
Derkwoo
 0.30 
 6,720 
Daeduck
 1.32 
 45,900 
Hyundai
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Market Performance
(90 Days Performance)
OK
Very Weak
Weak
Very Weak
Very Weak
OK
Very Weak
OK
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Below Average
Low
About Average
Low
Low
Low
About Average
Low
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Cautious Hold
Strong Sell
Sell
Strong Sell
Current Ratio
1.94
N/A
4.8
2.85
0.77
2.15
N/A
N/A
N/A
Net Asset
45.41 B
N/A
53.48 B
62.75 B
98.2 B
172.49 B
N/A
N/A
N/A
Profit Margin
-0.0598
N/A
0.0065
0.074
1.12
0.15
N/A
N/A
N/A
EBITDA
986.78 M
N/A
847.26 M
5.82 B
(12.32 B)
15.69 B
N/A
N/A
N/A
Operating Margin
-0.0405
N/A
-9.0E-4
0.13
-0.42
0.17
N/A
N/A
N/A
Current Valuation
68.82 B
N/A
65.96 B
177.07 B
97.74 B
99.21 B
N/A
N/A
N/A
Retained Earnings
33.78 B
N/A
(11.68 B)
N/A
(8.43 B)
61.16 B
N/A
N/A
N/A
Current Asset
41.55 B
N/A
29.15 B
N/A
18.81 B
37.84 B
N/A
N/A
N/A
Beta
1.39
N/A
1.17
1.59
0.97
0.65
N/A
N/A
N/A
Number Of Employees
204
N/A
128
78
99
42
N/A
N/A
N/A
Shares Outstanding
6.85 M
N/A
37.42 M
18.38 M
10.3 M
15 M
N/A
N/A
N/A
Cash Flow From Operations
3.32 B
N/A
450.79 M
6.74 B
(15.52 B)
6.72 B
N/A
N/A
N/A
Annual Yield
N/A
N/A
N/A
0.0131
N/A
0.0313
N/A
N/A
N/A
Total Debt
10.3 B
N/A
25.53 M
61.07 M
465.35 M
6.76 B
N/A
N/A
N/A
Return On Equity
-18.36
N/A
25.36
13.43
1.6
16.71
N/A
N/A
N/A
Z Score
1.8
N/A
N/A
N/A
64.8
5.4
N/A
N/A
N/A
Return On Asset
-0.02
N/A
-3.0E-4
0.05
-0.1
0.0594
N/A
N/A
N/A
Book Value Per Share
9099.02
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Liabilities
20.92 B
N/A
6.08 B
N/A
22.44 B
12.27 B
N/A
N/A
N/A
Total Asset
45.41 B
N/A
53.48 B
62.75 B
98.2 B
172.49 B
N/A
N/A
N/A
Debt To Equity
1.06
N/A
0.01
0.02
3.65
0.16
N/A
N/A
N/A
Target Price
31397.0
N/A
19150.0
N/A
N/A
N/A
N/A
N/A
N/A
Shares Owned By Institutions
N/A
N/A
0.12
0.7
N/A
N/A
N/A
N/A
N/A
Market Capitalization
34.45 B
N/A
61.86 B
113.98 B
50.7 B
66.82 B
N/A
N/A
N/A
Price To Earning
30.99
N/A
19.47
N/A
N/A
10.68
N/A
N/A
N/A
Price To Sales
0.7
N/A
1.86
2.49
1.32
0.78
N/A
N/A
N/A
Net Income
(4.33 B)
N/A
(286.51 M)
4.14 B
58.02 B
21.88 B
N/A
N/A
N/A
Shares Owned By Insiders
25.49
N/A
12.06
28.61
19.57
55.79
N/A
N/A
N/A
Revenue
38.41 B
N/A
22.98 B
34.66 B
47.47 B
93.03 B
N/A
N/A
N/A
Working Capital
20.63 B
N/A
23.08 B
N/A
(3.63 B)
25.58 B
N/A
N/A
N/A
Cash And Equivalents
17.19 B
N/A
8.88 B
22.95 B
51.85 B
7.13 B
N/A
N/A
N/A
Cash Per Share
N/A
N/A
N/A
N/A
817.91
N/A
N/A
N/A
N/A
Gross Profit
9.1 B
N/A
17.4 B
32.49 B
11.64 B
23.88 B
N/A
N/A
N/A
Day Typical Price
21516.67
2918.33
5676.67
2968.33
3901.67
4050.0
4863.33
6713.33
45866.67
Accumulation Distribution
0.0756
0.0482
20987.91
1241.81
180.25
357.27
1604.77
517.87
115.57
Market Facilitation Index
1700.0
145.0
3.0E-4
0.0024
0.0154
0.0044
0.0058
0.0018
0.0301
Daily Balance Of Power
(0.59)
(0.66)
1.0
0.7895
(0.14)
(0.38)
(0.47)
0.25
1.5
Period Momentum Indicator
(1,000.00)
(95.00)
190.0
75.0
(15.00)
(30.00)
(100.00)
20.0
600.0
Rate Of Daily Change
0.96
0.97
1.03
1.03
1.0
0.99
0.98
1.0
1.01
Day Median Price
21650.0
2937.5
5665.0
2967.5
3917.5
4055.0
4857.5
6710.0
45850.0
Price Action Indicator
(900.00)
(105.00)
130.0
40.0
(55.00)
(30.00)
(32.50)
20.0
350.0
Coefficient Of Variation
1078.85
(3,150)
8486.63
(967.49)
(1,624)
794.62
(1,160)
731.19
(3,239)
Mean Deviation
4.6
3.05
3.08
1.4
2.36
0.9085
1.85
0.6259
0.9701
Jensen Alpha
0.5638
(0.14)
0.0459
(0.23)
(0.19)
0.1843
(0.23)
0.113
(0.05)
Total Risk Alpha
0.3812
(0.27)
(0.08)
(0.29)
(0.28)
0.1381
(0.32)
0.0866
(0.09)
Sortino Ratio
0.1233
N/A
0.0051
N/A
N/A
0.1525
N/A
0.1114
N/A
Downside Variance
18.36
N/A
13.02
N/A
N/A
1.08
N/A
0.6423
N/A
Standard Deviation
6.05
4.32
4.31
2.1
3.04
1.51
2.71
0.8879
1.32
Kurtosis
1.85
2.26
3.43
3.84
(0.20)
6.15
4.82
5.69
0.4452
Potential Upside
12.95
8.63
6.79
2.95
4.38
3.96
4.35
1.21
2.21
Treynor Ratio
(0.92)
0.3121
(0.18)
2.65
0.7235
(1.05)
0.5973
(1.63)
0.5355
Maximum Drawdown
31.77
27.91
25.39
11.98
13.39
8.53
16.45
5.99
6.48
Variance
36.58
18.64
18.55
4.41
9.22
2.29
7.35
0.7884
1.74
Market Risk Adjusted Performance
(0.91)
0.3221
(0.17)
2.66
0.7335
(1.04)
0.6073
(1.62)
0.5455
Risk Adjusted Performance
0.0821
(0.02)
0.0175
(0.08)
(0.04)
0.1045
(0.06)
0.1094
(0.02)
Skewness
1.2
0.2171
1.17
(0.35)
0.1172
2.08
(1.02)
1.31
0.1451
Semi Deviation
3.99
N/A
3.45
N/A
N/A
0.6847
N/A
0.5403
N/A
Information Ratio
0.0874
(0.04)
0.0043
(0.12)
(0.07)
0.1046
(0.1)
0.1005
(0.06)
Value At Risk
(7.11)
(5.60)
(6.53)
(3.66)
(4.97)
(1.72)
(3.81)
(1.20)
(2.33)
Expected Short fall
(5.96)
N/A
(3.68)
N/A
N/A
(1.29)
N/A
(0.86)
N/A
Downside Deviation
4.28
N/A
3.61
N/A
N/A
1.04
N/A
0.8015
N/A
Semi Variance
15.9
N/A
11.91
N/A
N/A
0.4688
N/A
0.2919
N/A

Genic Competition Performance Charts

Five steps to successful analysis of Genic Competition

Genic's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Genic in relation to its competition. Genic's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Genic in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Genic's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Genic, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Genic position

In addition to having Genic in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Tech Funds Thematic Idea Now

Tech Funds
Tech Funds Theme
Funds or Etfs that invest in companies involved in research, development, testing, or distribution of technologically based goods and services. The Tech Funds theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Tech Funds Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Genic Stock

Genic financial ratios help investors to determine whether Genic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Genic with respect to the benefits of owning Genic security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY